EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma

Author:

Apfelbaum April A.12ORCID,Wu Feinan3,Hawkins Allegra G.4ORCID,Magnuson Brian5ORCID,Jiménez Jennifer A.1ORCID,Taylor Sean D.2,Wrenn Emma D.2ORCID,Waltner Olivia6ORCID,Pfaltzgraff Elise R.7,Song Jane Y.8,Hall Cody9,Wellik Deneen M.10ORCID,Ljungman Mats11,Furlan Scott N.612ORCID,Ryan Russell J.H.8ORCID,Sarthy Jay F.612,Lawlor Elizabeth R.212ORCID

Affiliation:

1. 1Cancer Biology PhD Program, University of Michigan, Ann Arbor, Michigan.

2. 2Seattle Children's Research Institute, Seattle, Washington.

3. 3Genomics and Bioinformatics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington.

4. 4Childhood Cancer Data Lab Alex's Lemonade Stand Foundation, Philadelphia, Pennsylvania.

5. 5Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.

6. 6Fred Hutch Cancer Research Center, Seattle, Washington.

7. 7Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

8. 8Immunology Discovery, Genentech, Inc., South San Francisco, California.

9. 9Department of Pathology, University of Michigan, Ann Arbor, Michigan.

10. 10Department of Cell and Regenerative Biology, University of Wisconsin, Madison, Wisconsin.

11. 11Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

12. 12Department of Pediatrics, University of Washington, Seattle, Washington.

Abstract

Abstract Purpose: Propagation of Ewing sarcoma requires precise regulation of EWS::FLI1 transcriptional activity. Determining the mechanisms of fusion regulation will advance our understanding of tumor progression. Here we investigated whether HOXD13, a developmental transcription factor that promotes Ewing sarcoma metastatic phenotypes, influences EWS::FLI1 transcriptional activity. Experimental Design: Existing tumor and cell line datasets were used to define EWS::FLI1 binding sites and transcriptional targets. Chromatin immunoprecipitation and CRISPR interference were employed to identify enhancers. CUT&RUN and RNA sequencing defined binding sites and transcriptional targets of HOXD13. Transcriptional states were investigated using bulk and single-cell transcriptomic data from cell lines, patient-derived xenografts, and patient tumors. Mesenchymal phenotypes were assessed by gene set enrichment, flow cytometry, and migration assays. Results: We found that EWS::FLI1 creates a de novo GGAA microsatellite enhancer in a developmentally conserved regulatory region of the HOXD locus. Knockdown of HOXD13 led to widespread changes in expression of developmental gene programs and EWS::FLI1 targets. HOXD13 binding was enriched at established EWS::FLI1 binding sites where it influenced expression of EWS::FLI1-activated genes. More strikingly, HOXD13 bound and activated EWS::FLI1-repressed genes, leading to adoption of mesenchymal and migratory cell states that are normally suppressed by the fusion. Single-cell analysis confirmed that direct transcriptional antagonism between HOXD13-mediated gene activation and EWS::FLI1-dependent gene repression defines the state of Ewing sarcoma cells along a mesenchymal axis. Conclusions: Ewing sarcoma tumors are comprised of tumor cells that exist along a mesenchymal transcriptional continuum. The identity of cells along this continuum is, in large part, determined by the competing activities of EWS::FLI1 and HOXD13. See related commentary by Weiss and Bailey, p. 4360

Funder

National Cancer Institute

National Institutes of Health

1 million 4 Anna Foundation

Alex's Lemonade Stand Foundation for Childhood Cancer

University of Michigan

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3